GBA1 and Parkinson disease: In particular, it has been observed that some metabolites of dopamine oxidation, such as 6-hydroxydopamine, play a role in PD [387], e.g., through increased mitochondrial ROS and inhibition of glucocerebrosidase—a lysosomal enzyme involved in the pathogenesis of PD [388,389].